Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Cell Reports|December 15, 2021
Self-renewal equality in pancreas homeostasis, regeneration, and cancerChiara Falcomatà, Dieter SaurCancer Research|July 14, 2023
Dual Recombinase-Based Mouse Models Help Decipher Cancer Biology and Targets for TherapyTina Sket, Chiara Falcomatà, Dieter SaurCancer Discovery|January 11, 2020
Personalizing <i>KRAS</i>-Mutant Allele-Specific TherapiesChiara Falcomatà, Günter Schneider, Dieter SaurJournal of Visualized Experiments : Jove|October 25, 2022
Syngeneic Mouse Orthotopic Allografts to Model Pancreatic CancerConstantin Schmitt, Dieter Saur, Stefanie Bärthel, et al.Current Opinion in Genetics & Development|May 12, 2019
Deciphering the universe of genetic context-dependencies using mouse models of cancerChiara Falcomatà, Stefanie Bärthel, Günter Schneider, et al.Nature Cancer|March 24, 2023
Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapyStefanie Bärthel, Chiara Falcomatà, Roland Rad, et al.Cancer Discovery|January 9, 2023
Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic CancerChiara Falcomatà, Stefanie Bärthel, Günter Schneider, et al.Nature Communications|May 8, 2023
Cell-selective proteomics segregates pancreatic cancer subtypes by extracellular proteins in tumors and circulationJonathan J Swietlik, Stefanie Bärthel, Chiara Falcomatà, et al.Biorxiv : the Preprint Server for Biology|July 16, 2025
Plasminogen activator inhibitors orchestrate the immunosuppressive tumor microenvironment in pancreatic cancerChiara Falcomatà, Sebastian R Nielsen, Maximilian M Schaefer, et al.European Journal of Cancer (Oxford, England : 1990)|December 21, 2016
Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patientsAndrea Sartore-Bianchi, Filippo Pietrantonio, Alessio Amatu, et al.Pageof 3